Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value | Revenue |
|---|
| EBITDA |
|---|
| Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
CI CI Cigna Group FY ended Jan 30, 2026 | $278.88 | $73.69B | $142.23B | $274.90B | $10.87B | $6.29B | 12.57x | 0.27x | 13.08x |
MO MOH MOLINA HEALTHCARE, INC. FY ended Feb 06, 2026 | $200.00 | $10.44B | $11.80B | $45.43B | $796.00M | $472.00M | 22.42x | 0.23x | 12.03x |
TD TDOC Teladoc Health, Inc. FY ended Feb 17, 2026 | $6.50 | $1.18B | $1.38B | $2.53B | $150.44M | -$200.32M | -5.70x | 0.47x | 4.18x |
CL CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE FY ended Dec 31, 2025 | $4.23 | $2.22B | $2.09B | $1.92B | -$85.24M | -$85.55M | -9.61x | 1.15x | — |
UN UNH UNITEDHEALTH GROUP INC FY ended Feb 20, 2026 | $392.95 | $352.71B | $430.82B | $447.57B | $20.65B | $12.06B | 29.70x | 0.79x | 16.33x |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 14.13x | 4/5 | -$6.23B | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 0.58x | 5/5 | $1.09B | $9.64 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 9.88x | 5/5 | -$5.28B | — | Target fundamentals do not produce a usable positive equity value. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
CI CI Cigna Group FY ended Jan 30, 2026 | $278.88 | $73.69B | $142.23B | $274.90B | $10.87B | $6.29B | 12.57x | 0.27x | 13.08x |
MO MOH MOLINA HEALTHCARE, INC. FY ended Feb 06, 2026 | $200.00 | $10.44B | $11.80B | $45.43B | $796.00M | $472.00M | 22.42x | 0.23x | 12.03x |
TD TDOC Teladoc Health, Inc. FY ended Feb 17, 2026 | $6.50 | $1.18B | $1.38B | $2.53B | $150.44M | -$200.32M | -5.70x | 0.47x | 4.18x |
CL CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE FY ended Dec 31, 2025 | $4.23 | $2.22B | $2.09B | $1.92B | -$85.24M | -$85.55M | -9.61x | 1.15x | — |
UN UNH UNITEDHEALTH GROUP INC FY ended Feb 20, 2026 | $392.95 | $352.71B | $430.82B | $447.57B | $20.65B | $12.06B | 29.70x | 0.79x | 16.33x |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 14.13x | 4/5 | -$6.23B | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 0.58x | 5/5 | $1.09B | $9.64 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 9.88x | 5/5 | -$5.28B | — | Target fundamentals do not produce a usable positive equity value. |
